Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
about
Central Role of Glutamate Metabolism in the Maintenance of Nitrogen Homeostasis in Normal and Hyperammonemic BrainRole of astrocytic glutamate transporter in alcohol use disorderHIV-1, methamphetamine and astrocytes at neuroinflammatory CrossroadsSpinal Glutamate Transporters Are Involved in the Development of Electroacupuncture Tolerance.Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.Signals from the Fourth Dimension Regulate Drug RelapseBrain endothelial cells induce astrocytic expression of the glutamate transporter GLT-1 by a Notch-dependent mechanism.Glutamate Transport: A New Bench to Bedside Mechanism for Treating Drug AbuseTranscriptional Regulation of Glutamate Transporters: From Extracellular Signals to Transcription Factors.Inflammation, Glutamate, and Glia: A Trio of Trouble in Mood Disorders.Astroglia as a cellular target for neuroprotection and treatment of neuro-psychiatric disorders.An astroglial basis of major depressive disorder? An overview.TREK-1 mediates isoflurane-induced cytotoxicity in astrocytes.The role of glutamate transporters in the pathophysiology of neuropsychiatric disorders.Direct visualization of glutamate transporter elevator mechanism by high-speed AFM.Comparative proteomic analyses of the parietal lobe from rhesus monkeys fed a high-fat/sugar diet with and without resveratrol supplementation, relative to a healthy diet: Insights into the roles of unhealthy diets and resveratrol on function.Laquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.Neuroprotective potential of astroglia.Region-specific deletions of the glutamate transporter GLT1 differentially affect seizure activity and neurodegeneration in mice.Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways.Native DIGE proteomic analysis of mitochondria from substantia nigra and striatum during neuronal degeneration and its compensation in an animal model of early Parkinson's disease.Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.EAAT2 and the Molecular Signature of Amyotrophic Lateral Sclerosis.Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice.Kv1.3 activity perturbs the homeostatic properties of astrocytes in glioma.Pharmacologic rescue of hyperammonemia-induced toxicity in zebrafish by inhibition of ornithine aminotransferaseInhibition of p38 MAPK Signaling Regulates the Expression of EAAT2 in the Brains of Epileptic Rats
P2860
Q26749567-8C29D6C5-5E25-4957-8936-84AE05E35054Q26750910-8DF37C5D-62F3-46CA-8008-CE0DE187F45AQ28392199-9148BACA-F333-4E9D-9FC5-98B43595888FQ36743663-C3EA0135-B5B1-411E-9CD9-2C2B08678F91Q36812629-0C6DCB02-28EB-4D5A-AB5C-7D267546F89CQ37059772-76B045B3-9B13-409F-9DDF-4895D140A129Q38695805-89975888-F124-4637-AEB5-980EFB76F4B2Q38729846-51202F37-7A24-40AC-B2AC-6EF7DB3731B2Q38861849-73EC55E9-01BC-40BB-BB7D-471C814FCB2DQ38954648-1AA2DC8F-1C61-4483-8B76-1CFA9747876DQ39181656-090C5B72-D747-47F3-90B1-EF1D45C31B65Q39186841-759AE6FB-1DF1-4372-AE4A-8D262873CCE1Q41614682-BCCC6A0C-B81E-4735-964A-3E0B481252B4Q41693925-40BA56A2-47A3-4CB3-89DC-E56037C4B316Q42175041-6FF1EDC3-FB5D-4355-8C90-E62815A74012Q47145007-8FBC3DB1-F3E4-4F57-BBD1-DD14292DC6F7Q47211013-8F7FCCF7-90B0-4E57-8B4B-A40806D2E876Q47680320-0DEFF787-557E-4A4D-9A7F-E3C038352D5FQ47916378-1B5C597B-FAA0-4C50-9531-EDB0BE1DCDDCQ47928721-45E9FDAB-1C86-44FA-81F9-CEA7624390A0Q47947143-82B0E9E0-0EB2-43ED-B69F-1576DBC3A819Q48598969-6A43491C-C76B-4985-84C4-ECF1C8537075Q48631361-983E1065-A253-40DA-9E22-B09551E7507DQ51824569-E7DF7605-B9B4-40DC-A863-C207EED1A0B1Q52676393-9F753AE8-6306-4DA5-AB85-63B322356E5BQ54958641-9DA55E8B-8FC6-463F-81C8-E73DDB89C012Q58756503-5CF4CCB0-AEA5-4377-80A0-686A7AC8FC7CQ59138055-A20404C8-DE1E-4C6B-BD4D-BA36D5085768
P2860
Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Glutamate transporter EAAT2: r ...... gical and psychiatric disease.
@en
type
label
Glutamate transporter EAAT2: r ...... gical and psychiatric disease.
@en
prefLabel
Glutamate transporter EAAT2: r ...... gical and psychiatric disease.
@en
P2093
P2860
P1476
Glutamate transporter EAAT2: r ...... gical and psychiatric disease.
@en
P2093
Chien-Liang Glenn Lin
Joshua B Foster
Kou Takahashi
P2860
P2888
P304
P356
10.1007/S00018-015-1937-8
P577
2015-06-02T00:00:00Z